GE HealthCare Technologies Inc. (GEHC)
Here's What Key Metrics Tell Us About GE HealthCare (GEHC) Q2 Earnings
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
GE HealthCare Technologies (GEHC) Tops Q2 Earnings Estimates
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $0.92 per share a year ago.
GE HealthCare's Stock Is Dropping After Earnings Beat. Here's Why.
GE HealthCare posts adjusted earnings per share of $1 in the second quarter, higher than estimates of 98 cents.
GE Healthcare's stock tumbles after revenue miss, free cash flow turns more negative
Shares of GE Healthcare Technologies Inc. GEHC tumbled 9.3% in premarket trading Wednesday, after the medical technologies and diagnostics company reported second-quarter revenue that missed expectations and cash flow that was more negative. Net income rose to $428 million, or 93 cents a share, from $418 million, or 91 cents a share, in the same period a year ago.
Lower Volume Likely to Hurt GE HealthCare's (GEHC) Q2 Earnings
GE HealthCare's (GEHC) second-quarter results are likely to witness declining segmental revenues in imaging, ultrasound and patient care. The bottom-line results may reflect better pricing.
3 Healthcare Stocks to Buy Now: Q3 Edition
After taking a backseat in the first half, the healthcare sector is finally coming to life. The rising odds of a Trump presidency have improved prospects for the industry, validating the case for increasing positions in healthcare stocks to buy now.
GE HealthCare (GEHC) New Deal to Aid Its Ultrasound Portfolio
GE HealthCare (GEHC) announces that it has entered into an agreement to acquire Intelligent Ultrasound's AI software business to strengthen its ultrasound portfolio.
GE HealthCare's (GEHC) New Solution to Aid Prostate Treatment
GE HealthCare's (GEHC) MIM Software introduced the MIM Symphony HDR Prostate to provide direct tumor visualization using MRI images during live ultrasound procedures for HDR prostate treatments.
GE HealthCare: Near-Term Risks, But Some Interesting Longer-Term Opportunities
GE HealthCare's near-term outlook creates near-term execution risk given the need for a strong 2H'24 ramp, but the longer-term potential may be underrated by the Street. GE HealthCare is a strong #2 in imaging behind Siemens Healthineers; while the company lags in photon-counting CT, its silicon-based approach could be the better one long term. I believe the Street is underestimating the potential of new markets in ultrasound (PoC, surgery, and peripheral), as well as high-margin growth in PDx tied to Alzheimer's, cardiology, and oncology.
GE Healthcare (GEHC) Enters Partnership to Boost MRI Technology
GE Healthcare Technologies, Inc. GEHC, in collaboration with the University of Cincinnati (UC), UC Health, and Cincinnati Children's, has announced a cutting-edge initiative to accelerate MRI innovation. This collaboration will provide a well-established MRI Research and Development (R&D) center of excellence on UC's medical campus, enabling direct interaction between clinical investigators and GE HealthCare scientists.
GE HealthCare's (GEHC) New Tie-Up to Boost CVD Workflow
GE HealthCare's (GEHC) latest collaboration is likely to enable clinicians to perform complex cardiology interventions with a high level of precision and improved image quality.
GE HealthCare (GEHC) Boosts Interventional Radiology Capabilities
GE HealthCare's (GEHC) latest successful first installation and clinical cases using the OmnifyXR are likely to improve clinical and operational outcomes for both patients and clinicians.
